Evidence map›Paper›PMID 37686073›Full record

ReviewInternational journal of molecular sciences2023

miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach.

Francesca Salvatori, Elisabetta D'Aversa, Maria Luisa Serino, Ajay Vikram Singh, Paola Secchiero, Giorgio Zauli, Veronica Tisato, Donato Gemmati

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Epigenetic Mechanisms in Heart Diseases.Reviews in cardiovascular medicine · 2025
    Review
  6. Review
  7. Review
  8. Investigating the role of inflammatory cytokines in mediating the effect of gut microbiota on gastrointestinal cancers: a mendelian randomization study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Article
  9. Review
  10. Current Research for Heart Disease Biology and Therapeutics.International journal of molecular sciences · 2024
    Article
  11. Review
  12. Unlocking the Transcriptional Control ofInternational journal of molecular sciences · 2024
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Francesca SalvatoriDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0001-8950-9978
Elisabetta D'AversaDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Maria Luisa SerinoCentre Haemostasis & Thrombosis, University of Ferrara, 44121 Ferrara, Italy.
Ajay Vikram SinghDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), 10589 Berlin, Germany.ORCID 0000-0002-9875-7727
Paola SecchieroDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Giorgio ZauliDepartment of Environmental Science and Prevention, University of Ferrara, 44121 Ferrara, Italy.
Veronica TisatoDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0001-8448-066X
Donato GemmatiDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0001-6213-6120
University of Ferrara · ITFederal Institute for Risk Assessment · DE

Funding

University of Ferrara FAR and FIRD
6 · The paper itself

Abstract

Myocardial infarction (MI) is one of the leading causes of death in Western countries. An early diagnosis decreases subsequent severe complications such as wall remodeling or heart failure and improves treatments and interventions. Novel therapeutic targets have been recognized and, together with the development of direct and indirect epidrugs, the role of non-coding RNAs (ncRNAs) yields great expectancy. ncRNAs are a group of RNAs not translated into a product and, among them, microRNAs (miRNAs) are the most investigated subgroup since they are involved in several pathological processes related to MI and post-MI phases such as inflammation, apoptosis, angiogenesis, and fibrosis. These processes and pathways are finely tuned by miRNAs via complex mechanisms. We are at the beginning of the investigation and the main paths are still underexplored. In this review, we provide a comprehensive discussion of the recent findings on epigenetic changes involved in the first phases after MI as well as on the role of the several miRNAs. We focused on miRNAs function and on their relationship with key molecules and cells involved in healing processes after an ischemic accident, while also giving insight into the discrepancy between males and females in the prognosis of cardiovascular diseases.

Indexed as

MicroRNAsMyocardial InfarctionApoptosisEpigenesis, GeneticEpigenomicsFemaleHumansMaleMicroRNAsepidrugsepigenetic tuningmiRNAsmyocardial infarctionsex-gap

Identifiers

PMID37686073
PMCPMC10487654
OpenAlexW4386222116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.